[go: up one dir, main page]

HK1116674A - Glutamate modulating agents in the treatment of mental disorders - Google Patents

Glutamate modulating agents in the treatment of mental disorders Download PDF

Info

Publication number
HK1116674A
HK1116674A HK08107450.0A HK08107450A HK1116674A HK 1116674 A HK1116674 A HK 1116674A HK 08107450 A HK08107450 A HK 08107450A HK 1116674 A HK1116674 A HK 1116674A
Authority
HK
Hong Kong
Prior art keywords
treatment
mental disorders
modulating agents
glutamate modulating
glutamate
Prior art date
Application number
HK08107450.0A
Other languages
Chinese (zh)
Inventor
Vladimir Coric
John H. Krystal
Gerard Sanacora
Original Assignee
Yale University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yale University filed Critical Yale University
Publication of HK1116674A publication Critical patent/HK1116674A/en

Links

HK08107450.0A 2005-04-05 2006-04-05 Glutamate modulating agents in the treatment of mental disorders HK1116674A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US60/668,735 2005-04-05
US60/669,774 2005-04-07
US60/690,187 2005-06-13
US60/694,621 2005-06-27
US60/756,472 2006-01-04

Publications (1)

Publication Number Publication Date
HK1116674A true HK1116674A (en) 2009-01-02

Family

ID=

Similar Documents

Publication Publication Date Title
IL184363A0 (en) Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
ZA200806114B (en) Use of sulfonamide derivatives in the treatment of disorders of the metabolism and the nervous system
IL195819A0 (en) Modulators of metabolism and the treatment of disorders related thereto
ZA200900055B (en) Modulators of metabolism and the treatment of disorders related thereto
IL232313A (en) Modulators of indoleamine 2,3-dioxygenase and methods of using the same
IL195906A0 (en) Alpha-aminoamide derivatives useful in the treatment of cognitive disorders
EP1893216A4 (en) Methods and compositions for the treatment of ocular disorders
IL180078A (en) 9-cis-retinal derivative for use in the treatment of 11-cis -retinal deficiency
WO2006127900A3 (en) Tl1a in the treatment of disease
EP1912650B8 (en) Use of flibanserin in the treatment of obesity
HUE050758T2 (en) Glutamate modulating agents in the treatment of mental disorders
IL181777A0 (en) Gpr43 and modulators thereof for the treatment of metabolic-related disorders
HK1116674A (en) Glutamate modulating agents in the treatment of mental disorders
EP1942911A4 (en) Therapeutic molecules and their uses
HK1119954A (en) Use of neboglamine in the treatment of toxicodependency
HK1111892A (en) Use of pyrazolyl-pyrimidine derivatives in the treatment of pain
HK1128920A (en) Modulators of metabolism and the treatment of disorders related thereto
HK1118542A (en) Imidazolyl-pyrimidine compounds for use in the treatment of proliferative disorders
HK1100009A (en) Gpr43 and modulators thereof for the treatment of metabolic-related disorders
AU2005901420A0 (en) Diagnosis and treatment of disorders
HK1122219A (en) Therapeutic molecules and their uses
EP1956001A4 (en) Pharmaceutical for use in the treatment of ureterolithiasis
HK1102521A (en) Methods and compositions for the treatment of gastrointestinal disorders
HK1104818A (en) Benzoxazocines and their therapeutic use